Studies of parvovirus vaccination in the dog: the performance of live attenuated feline parvovirus vaccines

Thompson, H.; McCandlish, I.A.; Cornwell, H.J.; Macartney, L.; Maxwell, N.S.; Weipers, A.F.; Wills, I.R.; Black, J.A.; Mackenzie, A.C.; Thompson, H; McCandlish, I.A; Cornwell, H.J; Macartney, L; Maxwell, N.S; Weipers, A.F; Wills, I.R; Black, J.A; Mackenzie, A.C

Home

>

Node

>

Subnode

Studies of parvovirus vaccination in the dog: the performance of live attenuated feline parvovirus vaccines

Thompson, H.; McCandlish, I.A.; Cornwell, H.J.; Macartney, L.; Maxwell, N.S.; Weipers, A.F.; Wills, I.R.; Black, J.A.; Mackenzie, A.C.

Veterinary Record 122(16): 378-385

1988

ISSN/ISBN: 0042-4900

PMID: 3394219

Document Number: 310969

The performance of three live attenuated feline parvovirus vaccines licensed for use in the dog was studied. At the end of the primary vaccination course 67% of dogs had inadequate antibody levels ( 32) as measured by a haemagglutination inhibition test. Interference by maternal antibody accounted for some of the failures but the fact that there was no significant difference in performance between dogs vaccinated at 12 weeks or 16 weeks of age indicated that maternal antibody was not the only factor.